リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Correlating diffusion-weighted MRI intensity with type 2 pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease<Abstract of dissertation>」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Correlating diffusion-weighted MRI intensity with type 2 pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease

Toshimasa Ikeda 池田 知雅 名古屋市立大学

2020.03.25

概要

Introduction: Although the sporadic Creutzfeldt-Jakob disease (sCJD) subtypes, with their distinctive clinicopathological features, have been identified based on two types of the abnormal prion protein (PrPSc), type 1 and type 2, and polymorphic codon 129 [1], there have been cases of both PrPSc types being present [2][3]. Because the clinical features in mixed PrPSc type sCJD were somewhat similar to the dominant PrPSc type but varied [4], the antemortem identification of both PrPSc types is not possible. On the other hand, the mixed PrPSc type features, especially in MM-type sCJD, have been best identified with neuropathological examination; the MM1-type involves fine vacuole-type spongiform change (FV), whereas the MM2C-type involves large confluent vacuole-type spongiform change (LCV) [5]. Our aim in this study was to predict the concurrence of MM-type sCJD with another type of PrPSc in the same individual before death and to reveal the relationship of clinical features and radiological findings in pathologically-mixed MM-type sCJD cases. We conducted both a retrospective clinicopathological case series and a regional systemic study to compare the pattern of spongiform change with hyperintensity on magnetic resonance diffusion-weighted imaging (DWI). This is the first study to statistically indicate the correlation of DWI intensity with the pattern of spongiform change.

Materials and Methods: We retrospectively identified seven MM-type sCJD cases with both fine vacuole-type spongiform (FV) and large confluent vacuole-type spongiform change (LCV) among 49 sCJD cases between 2008 and 2016. We reviewed clinical features, pathological findings, and radiological abnormalities in these seven cases. We also conducted a regional systemic study with 27 cortical subdivisions per hemisphere in 5 brains to associate the spongiform-change pattern with hyperintensity on DWI using the signal intensity index (SII).

Results: In the case series study, the one patient with dominant LCV showed longer disease duration, later onset of typical symptoms, no periodic sharp wave complexes in electroencephalography, and negative 14-3-3 protein findings compared to the six FV-dominant patients. LCV-dominant lesions tended to show higher intensity on DWI than did the FV-dominant lesions in respective patients. In the regional systemic study, LCV-dominant regions showed significantly higher SII on DWI than did the FV-dominant regions.

Conclusions: Mixed MM-type sCJD generally showed the clinical features of the phenotype that was dominant in pathological distribution. The SII may be clinically useful for investigating the concurrence of PrPSc type 2 in cases with the typical clinical course of MM1-type sCJD.

参考文献

[1] P. Parchi, A. Giese, S. Capellari, P. Brown, W. Schulz-Schaeffer, O. Windl, I. Zerr, H. Budka, N. Kopp, P. Piccardo, S. Poser, A. Rojiani, N. Streichemberger, J. Julien, C. Vital, B. Ghetti, P. Gambetti, H. Kretzschmar, Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects, Ann Neurol. 46 (1999) 224–233.

[2] P. Parchi, R. Strammiello, S. Notari, A. Giese, J.P.M. Langeveld, A. Ladogana, I. Zerr, F. Roncaroli, P. Cras, B. Ghetti, M. Pocchiari, H. Kretzschmar, S. Capellari, Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co- occurrence of PrPSctypes: An updated classification, Acta Neuropathol. 118 (2009) 659– 671.

[3] I. Nozaki, T. Hamaguchi, N. Sanjo, M. Noguchi-Shinohara, K. Sakai, Y. Nakamura, T. Sato, T. Kitamoto, H. Mizusawa, F. Moriwaka, Y. Shiga, Y. Kuroiwa, M. Nishizawa, S. Kuzuhara, T. Inuzuka, M. Takeda, S. Kuroda, K. Abe, H. Murai, S. Murayama, J. Tateishi, I. Takumi, S. Shirabe, M. Harada, A. Sadakane, M. Yamada, Prospective 10-year surveillance of human prion diseases in Japan, Brain. 133 (2010) 3043–3057.

[4] I. Cali, R. Castellani, A. Alshekhlee, Y. Cohen, J. Blevins, J. Yuan, J.P.M. Langeveld, P. Parchi, J.G. Safar, W.Q. Zou, P. Gambetti, Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: Its effect on the phenotype and prion-type characteristics, Brain. 132 (2009) 2643–2658.

[5] P. Parchi, L. De Boni, D. Saverioni, M.L. Cohen, I. Ferrer, P. Gambetti, E. Gelpi, G. Giaccone, J.-J. Hauw, R. Höftberger, J.W. Ironside, C. Jansen, F. Irccs, G.G. Kovacs, Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an interrater study among surveillance centres in Europe and USA, Acta Neuropathol. 124 (2012) 517–529.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る